Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004853
What this trial is testing

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Who this might be right for
Ewing's SarcomaRhabdomyosarcomaMPNST+2 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT03846362
What this trial is testing

A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML

Who this might be right for
Acute Myeloid Leukemia, Childhood
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 500
Testing effectiveness (Phase 2)UnknownNCT02144194
What this trial is testing

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

Who this might be right for
Breast Cancer
Cancer Research Group - Collaborative Group, Beirut, Lebanon. 65
Post-approval studies (Phase 4)WithdrawnNCT03792503
What this trial is testing

Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Xinqiao Hospital of Chongqing
Testing effectiveness (Phase 2)UnknownNCT00980603
What this trial is testing

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
National Cancer Center, Korea 144
Testing effectiveness (Phase 2)UnknownNCT03466827
What this trial is testing

Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma

Who this might be right for
ThymomaAdvanced Thymic Epithelial Tumour
Morten Mau-Soerensen 25
Large-scale testing (Phase 3)UnknownNCT04756622
What this trial is testing

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Who this might be right for
MucositisTransplant-Related Disorder
moshe yeshurun 116
Testing effectiveness (Phase 2)UnknownNCT02430974
What this trial is testing

Chemotherapy of NSCLC With or Without Icotinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Nanfang Hospital, Southern Medical University 50
Testing effectiveness (Phase 2)Study completedNCT02097303
What this trial is testing

Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis

Who this might be right for
Prostate Cancer
Carolina Research Professionals, LLC 36
Testing effectiveness (Phase 2)Ended earlyNCT03853317
What this trial is testing

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc. 9
Post-approval studies (Phase 4)Study completedNCT01020786
What this trial is testing

A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Study completedNCT03751761
What this trial is testing

GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study

Who this might be right for
Metastatic Gastric Cancer
Asan Medical Center 58
Testing effectiveness (Phase 2)Study completedNCT00440583
What this trial is testing

The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOP

Who this might be right for
Diffuse Large B-cell Lymphoma
Mahidol University 15
Testing effectiveness (Phase 2)Study completedNCT00780039
What this trial is testing

Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 58
Testing effectiveness (Phase 2)UnknownNCT02863471
What this trial is testing

Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma

Who this might be right for
Adenocarcinomas of the Pancreas
University Hospital Tuebingen 16
Not applicableStudy completedNCT02902575
What this trial is testing

The Safety and Feasibility of Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Stomach Neoplasms
Fujian Medical University 80
Testing effectiveness (Phase 2)WithdrawnNCT00712621
What this trial is testing

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

Who this might be right for
Breast Carcinoma
American Scitech International 460
Large-scale testing (Phase 3)Study completedNCT00790036
What this trial is testing

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 742
Not applicableLooking for participantsNCT05298722
What this trial is testing

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Who this might be right for
Pancreatic Cancer
University Hospital, Ghent 45
Not applicableLooking for participantsNCT06243731
What this trial is testing

Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Who this might be right for
Cytomegalovirus (CMV)Kidney DiseaseKidney Failure
Takeda 10
Next Page